Zurich. For the 51st time, the Prof. Dr. Max Cloëtta Foundation is presenting its renowned prize for medical research. This year, the prize is awarded for their outstanding research to: Professor Andrea Ablasser, lead researcher in innate immune systems at the EPFL (School of Life Sciences) in Lausanne, and Professor Andrea Alimonti, Director of the Institute of Oncology Research (IOR) in Bellinzona and Professor of Experimental Oncology at the Università della Svizzera italiana (USI) and ETH Zurich.

Andrea Ablasser
Professor Ablasser’s research has been groundbreaking in uncovering how the innate immune system detects and responds to DNA from pathogens. Her work has opened new avenues for the development of therapies aimed at modulating the immune response, offering potential treatments for a variety of diseases.

Recently, her studies have demonstrated how the cGAS-STING DNA-sensing pathway is involved in chronic inflammation and neurodegenerative diseases related to the aging process. These findings could lead to new strategies for combating these conditions.

Andrea Alimonti
The major scientific contributions of Professor Alimonti’s research include the discovery of a therapeutic approach based on the induction of cellular senescence and the immune response against tumors; the identification of an immune cell type, the so-called myeloid-derived suppressor cells, which can promote the progression of prostate cancer and resistance to standard therapies; and the discovery of a novel mechanism of therapy resistance in prostate cancer, involving the gut microbiome. Professor Alimonti’s vision is to develop cutting-edge, innovative treatments for cancer patients. Some of these treatments are currently being tested in clinical trials.

The award ceremony will take place at the EPFL on Friday, November 29, 2024, at 5 pm, at the hall SV 1717, Building SV, EPFL, Station 19, 1015 Lausanne.

Registration:

For mandatory registration, please use the following link https://qrco.de/bfSouR

Im Jahr 2024 verleiht die Stiftung Prof. Dr. Max Cloëtta den Cloëtta-Preis an zwei renommierte Wissenschaftler. Andrea Ablasser, führende Forscherin auf dem Gebiet der angeborenen Immunsysteme an der EPFL in Lausanne, und Andrea Alimonti, Direktor des Instituts für Onkologieforschung in Bellinzona und Professor für experimentelle Onkologie an der Università della Svizzera italiana und der ETH Zürich, erhalten den mit jeweils 50.000 Schweizer Franken dotierten Wissenschaftspreis.

Die Preisverleihung findet am 29. November 2024 um 17 Uhr an der EPFL statt.

Eine ausführliche Pressemitteilung wird im Herbst 2024 folgen.

Die Aufforderung zur Einreichung von Bewerbungen 2024 für Medizinische Forschungsstellen ist veröffentlicht worden.

Die Frist endet am 30. Juni 2024.

Hier finden Sie alle notwendigen Dokumente.

Der Aufruf zur Einreichung von Bewerbungen für die Clinical Medicine Plus-Stipendien 2024 ist jetzt geschlossen.

Stichtag war der 31. Mai 2024.

Die endgültige Auswahl wird Anfang Oktober 2024 stattfinden. Bis dahin bitten wir alle, die Bewerbungen eingereicht haben, um Geduld.